[1] Marazita M L, Ploughman L M, Rawlings B, et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population[J]. Am J Med Genet, 1993, 46(5):486-491. [2] Parker M, Bitner-Glindzicz M. Genetic investigations in childhood deafness[J]. Arch Dis Child, 2015, 100(3):271-278. [3] Sun W, Yang S M, Liu K, et al. Hearing loss and auditory plasticity[J]. Hear Res, 2017, 347: 1-2. [4] Akil O, Seal R P, Burke K, et al. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy[J]. Neuron, 2012, 75(2):283-293. [5] Yu Q, Wang Y, Chang Q, et al. Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice[J]. Gene Ther, 2014, 21(1):71-80. [6] Gao X, Tao Y, Lamas V, et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents[J]. Nature, 2018, 553(7687):217-221. [7] Li C W, Samulski R J. Engineering adeno-associated virus vectors for gene therapy[J]. Nat Rev Genet, 2020, 21(4):255-272. [8] 舒易来, 陶永, 李文妍, 等. 腺病毒转染新生及成年鼠内耳细胞的研究[J]. 中华细胞与干细胞杂志: 电子版, 2016, 6(5):302-306. [9] 齐景翠, 祖勉, 陈妮姗, 等. 9型腺相关病毒经圆窗膜转导小鼠耳蜗两种方式的对比研究[J]. 中华耳科学杂志, 2018, 16(4):469-473. [10] Ryan A F, Mullen L M, Doherty J K. Cellular targeting for cochlear gene therapy[J]. Adv Otorhinolaryngol, 2009, 66: 99-115. [11] Andres-Mateos E, Landegger L D, Unzu C, et al. Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate[J]. Nat Commun, 2022, 13(1):1359. [12] Devare J, Gubbels S, Raphael Y. Outlook and future of inner ear therapy[J]. Hear Res, 2018, 368: 127-135. [13] He L, Guo J Y, Qu T F, et al. Cellular origin and response of flat epithelium in the vestibular end organs of mice to Atoh1 overexpression[J]. Hear Res, 2020, 391: 107953. [14] Guo J Y, He L, Qu T F, et al. Canalostomy as a surgical approach to local drug delivery into the inner ears of adult and neonatal mice[J]. J Vis Exp, 2018(135):57351. [15] 王国鹏, 贺璐, 郭婧滢, 等. 腺相关病毒Anc80L65转染成年小鼠椭圆囊的实验研究[J]. 中华耳科学杂志, 2022, 20(1):21-25. [16] Gu X, Chai R J, Guo L, et al. Transduction of adeno-associated virus vectors targeting hair cells and supporting cells in the neonatal mouse cochlea[J]. Front Cell Neurosci, 2019, 13: 8. [17] 邓洪新, 田聆, 魏于全. 基因治疗的发展现状、问题和展望[J]. 生命科学, 2005, 17(3):196-199. [18] Naso M F, Tomkowicz B, Perry W L 3rd, et al. Adeno-associated virus (AAV) as a vector for gene therapy[J]. BioDrugs, 2017, 31(4):317-334. [19] Liu K, Ji F, Yang G, et al. SMAD4 defect causes auditory neuropathy via specialized disruption of cochlear ribbon synapses in mice[J]. Mol Neurobiol, 2016, 53(8):5679-5691. [20] 柳柯, 杨仕明. 内毛细胞传入神经突触病变和遗传性听功能障碍[J]. 中国医学文摘: 耳鼻咽喉科学, 2014, 29(5):291-293. [21] Wu X W, Zhang L, Li Y H, et al. Gene therapy via canalostomy approach preserves auditory and vestibular functions in a mouse model of Jervell and Lange-Nielsen syndrome type 2[J]. Nat Commun, 2021, 12(1):697. |